ECRON ACUNOVA A/S: Financial statements 2014
CVR: 10132029
Source: annual report 2014, Danish Business Authority
01/04/2013 – 31/03/2014
ECRON ACUNOVA A/S (CVR 10132029) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 11,682,064 and a net result of DKK -2,649,202 compared with DKK -2,511,684 the year before. The profit margin was -22.7%. Equity in the 2014 report amounted to DKK 524,188. The solvency ratio was 17.4%.
- Revenue
- DKK 11,682,064
- Gross Profit
- DKK 7,472,613
- Profit/Loss
- DKK -2,649,202
- Equity
- DKK 524,188
- Total Assets
- DKK 3,015,676
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 11.7 mio. | 7.5 mio. | -2.6 mio. | 524 t. | - |
| 2013 | - | 11.5 mio. | -2.5 mio. | 3.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of July 29, 2014, Anders Per Assar Malm has joined the board of directors of ECRON ACUNOVA A/S.
As of July 29, 2014, Klaus Dieter Wiedey has left the board of directors of ECRON ACUNOVA A/S.
As of July 29, 2014, Anders Per Assar Malm is registered as adm. dir. of ECRON ACUNOVA A/S.
As of July 29, 2014, Klaus Dieter Wiedey has stepped down as adm. dir. of ECRON ACUNOVA A/S.
As of June 24, 2014, Ecovis Danmark statsautoriseret revisionsinteressentskab has been appointed auditor of ECRON ACUNOVA A/S.
As of June 24, 2014, REVISIONSFIRMAET MBP ApS, REGISTRERET REVISOR has stepped down as auditor of ECRON ACUNOVA A/S.
About ECRON ACUNOVA A/S
ECRON ACUNOVA A/S was a Danish company of the type Aktieselskab based in København K, founded in 2003. The company has been dissolved on 3 February 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Navitas Life Sciences A/S and ACRONORDIC A/S. The company has 4 employees (2020). In 2019, the company reported a gross profit of DKK 3,746,121 and a net result of DKK -1,900,826 compared with DKK -3,186,181 the year before. Equity in the 2019 report amounted to DKK -4,321,670.